On April 25, the global technology event GITEX ASIA 2025 came to a successful conclusion at the Marina Bay Sands Convention and Exhibition Center in Singapore. As one of the largest and most influential technology exhibitions in Asia, the exhibition covers a number of hot fields, bringing together more than 1,000 technology companies and innovative start-ups from around the world, as well as many cutting-edge technology leaders in the industry, to jointly explore new trends in technology development in the fields of artificial intelligence, cybersecurity, and health technology.
Liverscan® enables full-process management of liver disease diagnosis and treatment
As an innovative enterprise deeply engaged in the field of liver disease diagnosis and treatment, Eieling is committed to providing accurate and reliable intelligent liver health diagnosis solutions to global healthcare providers. At the exhibition, the Eieling team made a grand appearance with Liverscan®. With its exclusive global patented technology and the advantages of being applicable in multiple scenarios, Liverscan® became one of the highlights of the exhibition. It demonstrated Eieling’s outstanding achievements in the field of liver disease diagnosis and treatment to experts, scholars, and potential customers from all over the world, and contributedto China’s strength in eliminating the harm of liver disease.
At present, the development of chronic liver disease in the world is not optimistic, and the disease burden continues to increase. Against this background, Liverscan®, launched by Eieling Technology, is equipped with the world’s exclusive patented technology for real-time B-mode ultrasound-guided transient elastography, which ensures the accurate presentation of liver stiffness value and acoustic attenuation parameters. It effectively reduces the missed diagnosis rate and misdiagnosis rate, blocks the progression of chronic liver disease, and is a new breakthrough in non-invasive diagnosis technology for liver disease.
Adhere to independent research and development to create a new era of liver disease diagnosis and treatment
At the exhibition, many domestic and foreign experts, scholars, and customers stopped to visit and showed great interest in Liverscan®’s portable wireless design and global exclusive patent. The Eieling team introduced the characteristics, advantages, and application scenarios of Liverscan® to global audiences and customers, and actively answered questions raised by customers on site. Combined with actual application scenarios, the excellent value of Liverscan® in liver disease health management was presented and won unanimous praise from customers. Through communication with customers, Eieling Technology further understood the market demand, which laid the foundation for subsequent in-depth cooperation.
Liverscan®’s wireless design breaks the shackles of traditional wired connections and can be widely used in primary liver screening, hospital outpatient clinics, scientific research and learning, and other fields. During the detection process, there is no need to replace the probe, which reduces maintenance costs. It can efficiently assist medical staff in performing liver testing and diagnosis for patients throughout the entire process of liver disease management, and achieve early detection and early intervention of chronic liver disease. With its excellent performance and efficient detection capabilities, Liverscan® has become an important tool for doctors in the diagnosis and treatment of liver diseases. Currently, Liverscan® has been installed in more than 10 countries and regions around the world and has been widely praised, and the coverage of service scenarios continues to expand.
Adhere to original research and innovation, benefit the people’s livelihood and welfare
Eieling Technology has always adhered to the development strategy of original research and innovation, and is committed to providing more accurate liver disease health diagnosis solutions for liver disease patients. After this exhibition, Eieling Technology will continue to be forward-looking in technological innovation, empower the development of non-invasive liver diagnosis and treatment technology, and benefit the people’s livelihood. In the future, Eieling will continue to strengthen its product lineup and break through the industry’s technical barriers. In response to the national call, it will firmly take steps towards internationalization and contribute Chinese wisdom and solutions to the global liver disease prevention and treatment cause.
